Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis

J Stagg, U Divisekera, N McLaughlin… - Proceedings of the …, 2010 - National Acad Sciences
Extracellular adenosine is a potent immunosuppressor that accumulates during tumor
growth. We performed proof-of-concept studies investigating the therapeutic potential and …

Radiosynthesis, preclinical, and clinical positron emission tomography studies of carbon-11 labeled endogenous and natural exogenous compounds

A Shegani, S Kealey, F Luzi, F Basagni… - Chemical …, 2022 - ACS Publications
The presence of positron emission tomography (PET) centers at most major hospitals
worldwide, along with the improvement of PET scanner sensitivity and the introduction of …

Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection

C Bastiancich, J Bianco, K Vanvarenberg… - Journal of controlled …, 2017 - Elsevier
Glioblastoma (GBM) treatment includes, when possible, surgical resection of the tumor
followed by radiotherapy and oral chemotherapy with temozolomide, however recurrences …

Morphological and immunocytochemical characteristics indicate the yield of early progenitors and represent a quality control for human mesenchymal stem cell …

F Haasters, WC Prall, D Anz, C Bourquin… - Journal of …, 2009 - Wiley Online Library
Human mesenchymal stem cells (hMSC) are a heterogeneous cell population, which is
reflected in varying morphological and biological properties. Three subpopulations with …

[PDF][PDF] Dual, enzymatic and non-enzymatic, function of ecto-5'-nucleotidase (eN, CD73) in migration and invasion of A375 melanoma cells

R Sadej, A Skladanowski - Acta Biochimica Polonica, 2012 - bibliotekanauki.pl
Ecto-5'-nucleotidase (eN, CD73) mediates extracellular adenosine production from 5'-AMP.
Non-enzymatic functions of eN have also been reported. The aim of the study was to …

[HTML][HTML] Ectonucleotidases in tumor cells and tumor-associated immune cells: an overview

LS Bergamin, E Braganhol, RF Zanin… - BioMed Research …, 2012 - hindawi.com
Increasing evidence points out that genetic alteration does not guarantee the development
of a tumor and indicates that complex interactions of tumor cells with the microenvironment …

[HTML][HTML] Decreased equilibrative nucleoside transporter 1 (ENT1) activity contributes to the high extracellular adenosine levels in mesenchymal glioblastoma stem-like …

S Alarcón, MÁ Toro, C Villarreal, R Melo, R Fernández… - Cells, 2020 - mdpi.com
Glioblastoma multiforme is one of the most malignant types of cancer. This is mainly due to a
cell subpopulation with an extremely aggressive potential, called glioblastoma stem-like …

[HTML][HTML] Passage-dependent relationship between mesenchymal stem cell mobilization and chondrogenic potential

AR Tan, E Alegre-Aguarón, GD O'Connell… - Osteoarthritis and …, 2015 - Elsevier
Objective Galvanotaxis, the migratory response of cells in response to electrical stimulation,
has been implicated in development and wound healing. The use of mesenchymal stem …

[HTML][HTML] Ecto-5'-nucleotidase expression is associated with the progression of renal cell carcinoma

YI Yu, W Wang, L Song, W Hu, C Dong… - Oncology …, 2015 - spandidos-publications.com
Renal cell carcinoma (RCC) is a common tissue tumor that occurs across all age groups and
has become one of the types of cancer with the fastest increasing incidence. Due to the …

Equilibrative nucleoside transporter 3 promotes the progression of hepatocellular carcinoma by regulating the AKT/mTOR signaling pathway

P Qin, J Yan, H Huang, Q Wang, M Li, Y Zhang… - International Journal of …, 2023 - Elsevier
Abstract Equilibrative nucleoside transporter 3 (ENT3) belongs to the solute carrier family
29. Nucleoside transporters encoded by ENT3 play an important role in the uptake of …